Among these targets, the expression levels of eight genes (CERCAM, PLOD1, FADS1, PAFAH1B2, PAX6, ADAM17, CCDC103, and PLXNA4) were closely associated with BC pathogenesis. This evidence concerns the gene PLXNA4 and breast cancer.